DNTH - Dianthus Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
35.6 0.66 (1.85%)	---	---	---	0.2 (0.56%)	0.92 (2.6%)	---	0.2 (0.56%)

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.88
Diluted EPS:: -0.88
Basic P/E:: -41.2034
Diluted P/E:: -41.2034
RSI(14) 1m:: 41.12
VWAP:: 36.25
RVol:: 0.6093

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	36.09 -0.38 (-1.04%)	Oct 15 12:54
1m	Price increase 1m	35.67 +0.37 (+1.04%)	Oct 15 11:35
1m	Price decrease 1m	35.65 -0.45 (-1.25%)	Oct 15 09:46
1m	Price increase 1m	36.1 +0.45 (+1.28%)	Oct 15 09:45
1m	Price decrease 1m	34.6 -0.74 (-2.09%)	Oct 15 09:30